Alterity Therapeutics ATHE
NASDAQ ATHE
$4.11 -0.39 (-8.67%)
At close: Sep 10, 2026 · 4:00 PM EDT

Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2026)

Alterity Therapeutics (ATHE) posted Prepaid Assets of $575839.5 for Q2 2026, up 12.44% on a QoQ basis from $512117.8 in Q4 2025, and down 89.75% year-over-year from $5.6 million in Q2 2025.

Analysis

Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2026) Analysis & Trends

Alterity Therapeutics has reported Prepaid Assets for 18 years, with the latest figure at $575839.5 in Q2 2026.

  • On a quarterly basis, Prepaid Assets fell 89.75% year-over-year to $575839.5 in Q2 2026; TTM through Jun 2026 was $575839.5, a 89.75% decrease from a year earlier, with the FY2026 full-year figure at $575839.5, down 89.75% from the prior year.
  • Prepaid Assets was $575839.5 for Q2 2026 at Alterity Therapeutics, up from $512117.8 in the prior quarter.
  • The five-year high for Prepaid Assets was $5.6 million in Q2 2025, with the low at $23563.0 in Q2 2024.
  • Average Prepaid Assets over 5 years is $1.2 million, with a median of $520809.4 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets slumped 97.74% in 2023, then jumped 23749.94% in 2025.
  • Over 5 years, Prepaid Assets stood at $520809.4 in 2022, then soared by 361.03% to $2.4 million in 2023, then slumped by 94.27% to $137668.3 in 2024, then soared by 271.99% to $512117.8 in 2025, then grew by 12.44% to $575839.5 in 2026.
  • The last three Prepaid Assets figures came in at $575839.5 (Q2 2026), $512117.8 (Q4 2025), and $5.6 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Alterity Therapeutics 72.80 Mn 72.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 575,839.54
Dec 31, 2025 512,117.76
Jun 30, 2025 5.62 Mn
Dec 31, 2024 137,668.33
Jun 30, 2024 23,563.00
Dec 31, 2023 2.40 Mn
Jun 30, 2023 26,092.86
Dec 31, 2022 520,809.36
Jun 30, 2022 1.15 Mn
Dec 31, 2021 1.17 Mn
Jun 30, 2021 843,790.23
Dec 31, 2020 254,870.38
Jun 30, 2020 378,922.26
Dec 31, 2019 211,606.15
Jun 30, 2019 442,536.67
Dec 31, 2018 80.85 Bn
Jun 30, 2018 201.84 Bn
Dec 31, 2017 300,146.52
Jun 30, 2017 247.60 Bn
Dec 31, 2016 107,128.62